NAKISA SERRY
GENERAL COUNSEL & CHIEF COMPLIANCE OFFICER
Nakisa Serry is the General Counsel, Chief Compliance Officer, and Board Secretary of Galderma Group AG. Joining in 2020 following its carve-out from Nestlé, she was instrumental in the company’s transformation and its March 2024 IPO on the SIX Swiss Exchange. Previously, she spent 14 years at Celgene Corporation (2006–2020) as Corporate Vice President and Associate General Counsel, where she established and led the international legal function until the company’s acquisition by Bristol Myers Squibb. Her earlier career includes serving as General Counsel at IsoTis SA, Senior Counsel at GSK Biologicals, and a consultant for the World Health Organization. She began her career in private practice, spending 7 years at Hoogendoorn, Talbot in Chicago.
Ms. Serry holds a BA from Northwestern University, a JD from the University of Denver, an LLM in Taxation from DePaul University College of Law and an MBA from IMD. She is also the Vice Chair of the Board of Directors for the International School of Lausanne.